S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
about
SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolismPosttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell BiologySplicing Regulators and Their Roles in Cancer Biology and TherapyRegulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in CancerThe role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionLeukotriene B₄ Metabolism and p70S6 Kinase 1 Inhibitors: PF-4708671 but Not LY2584702 Inhibits CYP4F3A and the ω-Oxidation of Leukotriene B₄ In Vitro and In CelluloEmerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung CancerA Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.Small Molecule Modulators of Pre-mRNA Splicing in Cancer TherapyFunctional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.Regulation of splicing by SR proteins and SR protein-specific kinases.S6K2: The Neglected S6 Kinase Family Member.Deregulation of splicing factors and breast cancer development.Inferring Intracellular Signal Transduction Circuitry from Molecular Perturbation Experiments.Alternative splicing of S6K1 promotes non-small cell lung cancer survival.Sam68 Regulates S6K1 Alternative Splicing during Adipogenesis.Ras-Erk signaling induces phosphorylation of human TLE1 and downregulates its repressor function.Considerations on mTOR regulation at serine 2448: implications for muscle metabolism studies.The role of RNA alternative splicing in regulating cancer metabolism.TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: relevance in human colorectal tumorsIdentification of recurrent regulated alternative splicing events across human solid tumors.Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation.Brassinosteriod Insensitive 2 (BIN2) acts as a downstream effector of the Target of Rapamycin (TOR) signaling pathway to regulate photoautotrophic growth in Arabidopsis.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Signaling pathways involved in the regulation of mRNA translation.
P2860
Q21132447-305A16D6-3D5B-472F-BEDA-59E65083A340Q26798154-AB2E906B-2D57-46A4-983E-EAB388E448E4Q26798158-95F7CA89-B216-4CB7-8CB5-D50D3F7C586FQ27001635-7386E68A-D916-49DA-8C37-0C16C76DFD88Q28083838-5FBE8B25-9380-4F27-9343-5033E087EC84Q28469468-31F9DC98-1777-4247-9A2C-DC723613936EQ34040857-F6126A7E-42F5-47C6-B57D-7E929DBF7015Q34157516-6C514ACC-6B13-4377-9B42-7F4D661577ACQ34240895-D3B225F2-B1FB-43DD-9EB3-45164097B283Q35993683-99162F08-4A1A-426F-A829-EB777EBD9D56Q36010786-E3B45125-6658-44CC-959F-29C36906F882Q36244787-9960A1FB-6044-49B7-9D94-C67CA32B2D47Q36447664-3AF7FAB7-40B5-449C-999D-5A1073AEC73DQ37457902-A0C16AFA-61AD-45DB-B43F-5247BD6B844DQ38092678-81423631-3D78-46C6-BED6-635DEA8F9C40Q38125196-36C5A96A-D976-4EB4-93CA-253F038847A6Q38463397-1E944978-338E-42A5-8C05-4185895D1794Q38705548-D7340D93-0D7D-4ED7-84E5-261028671ECBQ38755663-8B47BFBF-D2E1-41F7-BA38-0B704AE013A5Q38899164-B7C68013-330E-4D4F-9DE1-A7F1B32EDADDQ38964113-28E39658-FA15-44C5-B8BA-EB6285D27553Q39144817-412707F0-BE3C-44B4-B897-00100F8394BDQ39253959-73423DCC-0EAF-4135-9B4E-FF5FA19C0688Q41135356-B313D5B7-728C-4106-BC63-557B7C4613ADQ41193780-BDD263B8-8C0F-4502-8984-08D4FB3BBD59Q50468454-47C8567F-1A88-4F02-85AF-0DFCA3C047BAQ51602035-EBFA0C0B-61D2-47A7-8014-170EFEABA2EBQ52564290-14DE1510-7056-4D23-9363-A418CDDDDA5DQ54118148-0E3D0C69-D51C-4320-BFE1-4CFF4882F3B3
P2860
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
@en
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
@nl
type
label
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
@en
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
@nl
prefLabel
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
@en
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
@nl
P2093
P2860
P1433
P1476
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
@en
P2093
Avi Maimon
Ben Davidson
Polina Denichenko
Rotem Karni
Vered Ben-Hur
Zahava Siegfried
P2860
P304
P356
10.1016/J.CELREP.2012.11.020
P577
2012-12-27T00:00:00Z